Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2024-07-09 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued shares, treasury shares, share buybacks, and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) related to disclosure of share repurchases and changes in issued shares. The content includes detailed tables of share repurchase transactions, dates, prices, and confirmations of compliance with listing rules. This is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It fits the category of a company announcement regarding share repurchases and capital structure changes. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail confirm it is not a brief announcement but a full disclosure report on share repurchases.
2024-07-09 English
(Revised) Next Day Disclosure Return
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and details changes in issued shares, treasury shares, share buybacks, and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) related to disclosure of share repurchases and changes in issued shares. The content includes detailed tables of share repurchase transactions, cancellation of shares, and confirmations of compliance with listing rules. There is no financial performance data, earnings information, or management discussion. The document is a regulatory disclosure about share repurchase and capital changes, not a full financial report or earnings release. Therefore, it fits the category of a Share Issue/Capital Change announcement.
2024-07-09 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares, treasury shares, share buybacks, and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and details share repurchase transactions, including dates, prices, and quantities. The document is a regulatory disclosure about share repurchases and changes in share capital, not a full financial report or earnings release. It fits the category of a report on the company's transactions in its own shares (share buybacks). Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support a high confidence score.
2024-07-08 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and details changes in issued shares, treasury shares, share buybacks, and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) related to disclosure of share repurchases and changes in issued shares. The content includes detailed tables of share repurchase transactions, confirmation statements about compliance with listing rules, and repurchase mandate details. This type of document is a regulatory disclosure about transactions in the company's own shares, specifically share repurchases and treasury share sales. It is not a financial report, earnings release, or management discussion, but a formal announcement of share repurchase activity. According to the filing definitions, reports of the company buying back or selling its own shares fall under 'Transaction in Own Shares' (POS). The document length and detail confirm it is the report itself, not just an announcement of a report. Therefore, the correct classification is POS with high confidence.
2024-07-05 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and details changes in issued shares, treasury shares, share buybacks, and on-market sales of treasury shares for PW Medtech Group Limited. It includes specific data on share repurchases, cancellations, and confirmations of compliance with listing rules. The content focuses on share repurchase activities and changes in capital structure rather than financial results, management changes, or regulatory announcements. This matches the definition of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document is substantive and detailed, not merely an announcement or certification, so it is not classified as RPA or RNS.
2024-07-04 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares, treasury shares, share buybacks, and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and details share repurchase transactions, including dates, prices, and quantities. The document includes confirmations about compliance with listing rules and legal requirements related to share repurchases. There is no indication that this is a full financial report, earnings release, or management discussion. Instead, it is a regulatory disclosure about share repurchases and changes in capital structure. This fits the definition of a 'Transaction in Own Shares' filing, which covers company buybacks or sales of its own shares. The document length and detail confirm it is the report itself, not just an announcement of a report. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2024-07-03 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.